Clinical trial
VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
NCT00291187 · Vanda Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00291187 |
|---|---|
| Title | VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 and Matching Placebo in Healthy Male and Female Subjects With Induced Transient Insomnia |
| Lead sponsor | Vanda Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | 20 mg VEC-162, 50 mg VEC-162, 100 mg VEC-162, Placebo |
| Enrollment | 411 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Feb 13, 2006 |
| Last update posted | Oct 15, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: